Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • MARCH 2021 Issue has been successfully launched on 1 March 2021.



Solunke Rahul*, Bushetti S, Warad Shubhangi, Somwanshi Bhagwat.


Rizatriptan is an Anti-migraine & Anti-Inflammatory Agent used in the treatment of acute migraine attacks. After oral administration of tablet it undergo metabolism and resulting in to the inactive indole acetic acid derivative in turn which results into the decreased bioavailability (45%) of rizatriptan. So, in order to improve the bioavailability and efficacy of rizatriptan, we have prepared buccal patches of rizatriptan. With the preparation of buccal patches we are delivering the drug through buccal route by which we can bypass the presystemic metabolism of the rizatriptan. In the present piece of research work, Rizatriptan Buccal Patches were prepared using mucoadhesive polymers like HPMC, Chitosan, NaCMC & HEC by Solvent Casting technique. Buccal patches were characterized for number of parameters like physical appearance & surface texture, weight uniformity, thickness, folding endurance, swelling index, bursting strength, Surface pH, drug–Excipient interaction study, drug content uniformity and In vitro drug release study. Drug content uniformity study showed uniform dispersion of the drug throughout the formulation in the range of 96.477 ± 1.385 to 99.460 ± 0.147 %. Invitro drug release studies showed that more than 90% of the drug was released at the end of 10th hrs.

Keywords: Rizatriptan, Buccal Patches, Polymers, Mucoadhesion / Bioadhesion, In vitro

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More